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It can be said that the development of new and effective drugs becomes more es-
sential for all pharmaceutical companies. However, the process of drug development 
usually requires many clear steps. Through the long time of research and development 
including clinical trial, the candidate chemical compounds are screened from thou-
sands to one. It means that hundreds millions dollars’ cost and over 15 years’ time are 
needed. To make matters worse, success in the development is not guaranteed and so 
many failure projects exist. So drug development includes both high cost and high 
risk. 
To avoid this problem, drug repositioning is actively studied. Briefly saying, drug 
repositioning is reuse of existing drugs for other purposes. Since all existing drugs 
have already been developed and sold in the market, it is possible to greatly reduce 
the cost and time for research and development (R&D). One famous example of drug 
repositioning is about thalidomide. At first, it was developed for good sleep. Due to 
the serious side effect for pregnant women, once it was withdrawn. However, it was 
repositioned as anti-cancer drug, and actually used for cancer treatment. 
Besides biomedical experiments, computational methods are developed for drug 
repositioning. Most of them adopt network-based algorithms and combination of 
various databases including gene expression and pathway data. On the other hand, it 
is also suggested that text mining has much potential for drug repositioning. 
In this study, a text mining approach to the discovery of unknown drug-disease 
relation was tested. Starting from over 3 million PubMed abstracts related to cancer, 
biomedical named entities (i.e. drugs, genes, proteins, etc.) were first recognized and 
the relations among them were extracted. Biomedical ontologies such as PharmGKB, 
MeSH, DrugBank, and CTD databases were utilized for the sources of semantic 
information. Using a word embedding algorithm, senses of over 1.7 million words 
were well represented in sufficiently short feature vectors. Through various analysis 
including clustering and classification, feasibility of our approach was tested. Finally, 
our trained classification model achieved 87.6% accuracy in the prediction of drug-
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disease relation in cancer treatment and succeeded in discovering novel drug-disease 
relations that actually reported in recent studies.  
We strongly believe that word embedding is effective for representing sense of 
all words in large amount of cancer-related PubMed abstracts. Furthermore, concate-
nation of word vectors of drugs and diseases well represents their relations and could 
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Chapter 1   
Introduction 
 
In the first chapter we would like to introduce generally about our research which 
will be shown more detailed in the next chapters. Then, we briefly present the objec-
tives of this study. Next, the main contributions of my dissertation are mentioned 
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1.1 Overview of dissertation 
For pharmaceutical companies, the development of new, effective, and highly-
demanded drugs is important. To address this issue, hundreds million dollars and 10 
or more years for research and development (R&D) and clinical trial are typically 
required. Structure-based drug design (SBDD) is actively studied to reduce the cost 
and time by in-silico screening of candidate chemicals [1, 2], however, still it requires 
long time for tests on animals and human. Beside the high cost and long time, the 
development is not always guarantied and so many failure projects exist. It means that 
pharmaceutical development includes both high cost and high risk. 
Against such a background, a concept of drug repositioning (or drug repurpos-
ing, re-profiling, etc.) is attracting much interest and expectation from academic 
researchers and pharmaceutical companies [3]. One of the famous examples of drug 
repositioning is a treatment of multiple myeloma by thalidomide that was initially 
developed for relieving nausea and vomiting in pregnancy. Since drug repositioning 
means reuse of approved drugs for another purpose, their safety and method of 
production have already been confirmed.  
In recent years, besides biomedical experiments, computational methods are de-
veloped for drug repositioning. Most of them adopt network-based algorithms and 
combination of various databases including gene expression and pathway data [4]. On 
the other hand, it is also suggested that text mining has much potential for drug 
repositioning. In biomedical text mining, named entities (genes, proteins, etc.) are 
recognized and the relations among them are extracted (e.g. “Ge-
fitinib”<inhibit>“EGFR”). Additionally, biomedical ontologies or WordNet [5] are 
utilized for the sources of semantic information. 
In this study, we applied word embedding, implemented as word2vec [6-8], for 
efficient representation of semantic information of words in a sufficiently large subset 
of PubMed abstracts. Through the clustering and classification experiments especially 
on anti-cancer drugs and cancer-related diseases, it is suggested that the word vectors, 
generated by word embedding for drugs and diseases, are representing rich semantic 
information and promising for drug repositioning. 




Since discovering new indications of existing drugs plays an important role for 
pharmaceutical and academic institutes, our research aims to apply available biomedi-
cal databases and text mining techniques to the extraction of new knowledge about 
anti-cancer drugs from large amount of PubMed abstracts. 
The main objective of this thesis is to build a model which can predict unseen 
drug-disease relations based on biomedical word vectors and machine learning 
algorithms. 
1.3 Contributions 
In past decades, studies related to drug repositioning may contribute a lot of 
benefits for the development of new and effective drugs, especially for the develop-
ment of highly-demanded drugs such as anti-cancer drugs or anti-HIV drugs. 
This study mainly contributes to the following matters: 
The first application of word embedding for drug repositioning 
Unlike previous drug repositioning approaches, this study firstly applies word 
embedding model for the vector representation of biomedical words such as drugs, 
diseases, and genes. Word embedding, also called as distributed representation of 
words, is a new and effective word vector model which is broadly used in these years. 
Embedding words for drugs and diseases well reflects the meaning of them. 
Understanding the distribution of biomedical word sense 
From the result of cluster analysis for drug, disease, and gene word vectors, we 
can see the clear separation of word senses. This is essential for predicting the mean-
ing and class labels of biomedical entities like drugs, diseases, and genes. 
Generating new hypotheses about different indications of existing drugs 
With trained classifiers, we can predict new drug-disease relations which are 
considered as new hypotheses related to the cancer treatment. From these hypotheses, 
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along with pharmaceutical experts’ support, new indications of existing drugs may be 
found to cure cancer or related diseases. 
Reducing the cost and time to develop new anti-cancer drugs 
In contrast of traditional drug repositioning methods, the uniqueness of this 
study is that it is purely based on text mining. Therefore, it can be said that this study 
significantly contributes to the reduction of time and money for drug development.  
1.4 Thesis organization 
This thesis is organized into five chapters, including the current chapter intro-
ducing the context, objectives, contributions, and organization of our research. The 
remaining chapters are organized as follows: 
Chapter 2 reviews the backgrounds related to drug repositioning, text mining, 
and resources applied in the process of experiments. 
Chapter 3 explains about the overview of processing pipeline, materials, and 
algorithms used for cluster analysis and classification. 
Chapter 4 shows and discusses the obtained results from experiments. 
Chapter 5 summarizes the dissertation by giving conclusion of achievement 





























This chapter aims to briefly present fundamental knowledge and works related to 
drug repositioning and biomedical text mining for drug development. Then, we 
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2.1 Drug repositioning 
For most pharmaceutical companies or institutions, finding the process for devel-
oping new and effective drugs is essential. However, the ratio of successfully 
identified drugs is quite low because the process of drug discovery often requires long 
time, high cost and many steps to bring new drugs to the market.  
Through the long time of research and development including clinical trial, so 
many candidate chemical compounds are screened carefully in order to find lead 
compounds having good reactivity against pathways and single therapeutic targets. It 
means that hundreds millions dollars’ cost and over 15 years’ time are needed for this 
process. To make matters worse, success of the development is not always guaranteed 
and still so many failure projects exist. Therefore, we can say that drug development 
includes both high cost and high risk. 
Against such a background, a concept of drug repositioning (or drug repurposing, 
reprofiling, etc.) is attracting much interest and expectation from academic research-
ers and pharmaceutical companies [3]. Briefly saying, drug repositioning is reuse of 
existing drugs for other purposes. One of the famous examples of drug repositioning 
is a treatment of multiple myeloma by thalidomide that was initially developed for 
relieving nausea and vomiting in pregnant women. Since drug repositioning means 
reuse of approved drugs for other purposes, their safety and method of production 
have already been confirmed. 
Besides biomedical experiments, computational methods are developed for drug 
repositioning. Most of them adopt network-based algorithms and combination of 
various databases including gene expression and pathway data [4]. On the other hand, 
it is also suggested that text mining has much potential for drug repositioning as 
shown in figure 2.1. In biomedical text mining, named entities (genes, proteins, 
diseases, drugs, etc.) are recognized and the relations among them are extracted. 
Additionally, biomedical ontologies or WordNet [5] are utilized for the sources of 
semantic information. In the next section, we will introduce basic aspects of biomedi-
cal text mining and its resources for drug repositioning. 
 


















Figure 2.1 Main strategies of drug repositioning. 
(Source: http://www.gvkbio.com/drugrepurposing/approach/repurposing-algorithms/) 
 
2.2 Biomedical text mining 
2.2.1 Basic concepts 
Text mining 
In general, text mining is the process of extracting information or discovering 
knowledge automatically from textual data or unstructured data. The process of text 
mining is quite similar to the process of data mining. However, the input of data 
mining systems is structured data, whereas text mining systems’ input is unstructured 
data. Therefore, text mining needs to conduct the text preprocessing step in order to 
transform textual data into numerical data or structured data for further processing 
steps. Text mining is also known as an interdisciplinary area since it is related to 
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Biomedical text mining 
Biomedical text mining refers to the application of text mining to biomedical do-
main. Through biomedical text mining, useful knowledge, which is hidden in 
biomedical literature, can be extracted. For example, named biomedical entities (i.e. 



















Figure 2.2 Related fields of text mining.  
 
2.2.2 The process of text mining 
In general, the process of text mining can be divided into five main phases, in-
clude: 
 Text gathering 
 The process of text gathering is an important step for any text mining 
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The crucial goal of text mining systems is to extract useful information 
from collected texts which called corpus. To meet this goal, therefore, 
we need to collect appropriate text resources. 
 Choice of text resources for text mining systems depends on what kind 
of information we want to extract. For example, if we want to extract 
biomedical information, we can use PubMed abstracts as text resource. 
 
 Text preprocessing 
Text preprocessing includes the following tasks: 
 Tokenization 
Tokenization refers to the process which a text document is split into a 
set of words or terms (also called as tokens). However, before doing 
tokenization, special characters and punctuation need to be removed 
[9]. Words must be separated by white spaces. 
 Removing stop words 
Stop words typically refer to extremely frequent but meaningless 
words, for instance, articles (“a”, “an”, “the”), conjunctions (“and”, 
“or”, etc.), prepositions (“at”, “in”, “on”, etc.), and pronouns (“I”, 
“they”, “it”, etc.). These words should be removed in order to reduce 
the dimensionality of feature space. The most popular way to filter out 
stop words is based on an available list of stop words. It means that on-
ly words in the list will be filtered out from the corpus. 
 Stemming 
It is the process that the words of the same stem are reduced to their 
root or base form since they have equal or similar meaning. For exam-
ple, the plural nouns will be changed to their singular forms; the "ing" 
or "ed" verbs will also be transformed into bare verbs [10]. One of the 
most widely used algorithms for stemming is Porter’s algorithm [11].  
 Feature generation 
In this step, we transform unstructured text data into structured data for further 
processing steps. In other words, we need to change text data into numerical 
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data which is more appropriate to data mining algorithms. There are several 
ways of text representation such as Boolean model [12], Bag-of-Word model 
[13], and Word embedding model [7]. 
 
 Feature selection and/or dimension reduction 
In case that input data, represented as a set of feature vectors, contain some 
features irrelevant from class label or objective variable, they often cause low 
performance of data mining, text mining, or machine learning. Feature selec-
tion is a popular method of increasing the performance.  
Another serious problem about feature is so called “the curse of dimen-
sionality”. Feature vectors consist of many dimensions easily cause long 
computation time, memory space exhaustion, and low performance in mining 
and learning. To solve this problem, dimension reduction is commonly con-
ducted. Feature selection can be regarded as a kind of dimension reduction, 
however, there are other methods which compress high-dimensional feature 
vectors into low-dimensional ones. Traditional algorithms for dimension re-
duction or compression like Principal Component Analysis (PCA) and Latent 
Semantic Analysis (LSA).   
Since most of text representation methods yield high-dimensional feature 
vectors, it is necessary to conduct feature selection and/or dimension reduction 
to reduce the dimensionalities of the representation of documents. It helps the 
further process of data mining to become more effective. 
 
 Data mining 
The most important purpose of text mining systems is to discover useful and 
unknown information from collection of text documents by using machine 
learning or data mining techniques. Therefore, it can be said that this step 
plays an important role in the process of text mining. 
 
 Analyzing and evaluating results 
This stage is to examine, analyze and evaluate obtained results from the pro-
cess of data mining. From this, we can understand how well text mining 
systems work. 
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2.2.3 Approaches for text representation 
Before applying data mining techniques to text documents, these documents need 
to be transformed into structured data or computable data. Some models of proposed 
text representation are listed as follows: 
 Boolean model 
This model represents a document as a set of words or terms. If a term is pre-
sent in a document, its weight is assigned value 1 (otherwise, value 0). 
Therefore, these terms' weights are all binary values (0 or 1). From this, each 
corpus is represented by a two-dimension matrix. Columns of the matrix cor-
respond to all terms (vocabulary or dictionary) of corpus and rows correspond 
to the documents of corpus. 
For example, Table 2.1 shows a set of documents represented by Boolean 
model. Term weights are binary values (0 or 1) which mean if a term occurs in 
a document or not. 
Table 2.1 Text representation by Boolean model. 
 word 1 word 2 word 3 ... 
document 1 0 1 1 
... 
document 2 1 0 0 
... 
document 3 1 1 0 ... 
... ... ... ... ... 
 
It can be seen that this model has some drawbacks. Firstly, data space be-
comes extremely high dimensional and sparse. Secondly, since the importance 
level of terms is the same, it is hard to do feature selection. 
 Vector space model 
Vector space model, which is also known as bag-of-word model, was pro-
posed by Salton [13]. Since this model is quite simple and effective, it 
becomes one of the most popular models for text representation. Unlike Bool-
ean model, in this model a term’s weight is a real value which denotes its 
degree of importance in a document. There are various ways to compute term 
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weights. Among them, term frequency (tf) is the simplest weight which indi-
cates how many times a term presents in a document. In addition, Term 
Frequency-Inverse Document Frequency (tf.idf) is widely used for the term 
weight. This term weight was defined by Salton [14]. 
For example, table 2.2 show vector space model which is used to repre-
sent a set of documents. Term weights are the frequency of corresponding 
terms. 
Table 2.2 Text representation by vector space model. 
 word 1 word 2 word 3 ... 
document 1 0 6 2 
... 
document 2 1 0 0 
... 
document 3 4 3 0 ... 
... ... ... ... ... 
 
Although this model has considered the importance level of terms in a document, 
it still has some limitations which do not make it become an effective model for text 
representation. One serious problem of both Boolean and vector space models is that 
they can make the data space become extremely high dimensional and sparse (con-
taining so many zero values). Additionally, in this method the order and context of 
words in a sentence or are not considered. 
 
 Word embedding model 
To avoid limitations of two above models, Tomas Mikolov et al. [7] proposed 
word embedding model which is actively studied in these years. This model uses 
neural network to find a distributed representation of a word that is a short numerical 
vector (for example, 100 dimensions). This numerical vector is also called as a word 
vector. As a result of applying word embedding model, a set of word vectors (also 
known as word vector space) is generated by the methods called Continuous Bag of 
Words (CBOW) or Skip-gram. The former uses the context to predict a target word. 
In contrast, the latter uses a current word to predict surrounded words or the context 
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of a word. These algorithms are simple Neural Networks algorithms with only three 
layers as shown in Figure 2.3 
 
 
Figure 2.3 CBOW model and Skip-gram model. 
(Source: Tomas Mikolov 2013, ICLR Workshop) 
 
Unlike the previous models such as Boolean and vector space models, which only 
consider individual words for building the vector space, this model utilizes the context 
of each word to compute its vector representation. Therefore, the obtained vector 
space well represents the sense of words, that is, distance between two word vectors 
reflects the dissimilarity of two word senses. In addition, it is believed that, for 
various application domains, word analogy works well in this vector space. 
In a sense, word analogy is inference of relation. Suppose that we have an input 
of three words “Tokyo”, “Japan”, and “Vietnam”. Here, “Japan” and “Tokyo” repre-
sents a given relation, and “Vietnam” is a part of new relation. As a result of word 
analogy, the output “Hanoi” is returned as the word nearest to the calculated point X, 
that is, Tokyo - Japan + Vietnam. In figure 2.4, the three words are located in the 
space of word vector generated by word embedding. Then, the displacement vector 
between the first two words is calculated. Using the displacement vector and the 
vector of the third word, the point X is calculated. Finally, “Hanoi” is returned as the 
nearest word to X. 
INPUT           PROJECT          OUTPUT  INPUT       PROJECT            OUTPUT 
















Figure 2.4 An example of word analogy. 
 
2.2.4 Similarity measures 
Briefly saying, similarity measures (or distance measures) are functions which 
compute the level of similarity between two vectors (or objects) in the n-dimension 
space. For example, suppose that we have two documents represented as two vectors, 
similarity measure between two vectors means the similarity between two correspond-
ing documents. 
It can be said that similarity measure plays an important role for clustering algo-
rithms since it will affect directly the performance of clustering. Thus, different 
clustering algorithms can use different measures based on characteristics of data and 
application fields. Each measure has different characteristics that can be appropriate 
to the research problem or not. 
The following metrics are widely used to calculate the similarity between objects 
or vectors in data mining algorithms. 
 Euclidean distance 
For geometrical problems, Euclidean distance is a standard measure. In case of 
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documents da and db respectively. The Euclidean distance between the two 
documents is calculated by following equation: 
 




                                                           (𝐸𝑞. 2.1) 
 
where the term set is T = {t1, . . . , tm}; 𝑤𝑡,𝑎 and 𝑤𝑡,𝑏 are term a and b weights, 
respectively. 
 
 Cosine similarity 
Cosine similarity is one of widely-used similarity measures, especially in text 
mining. In this study, we also use this cosine similarity for our clustering algo-
rithms. Eq. 2.2 shows the formula of cosine similarity. 
 
𝑆𝐼𝑀𝐶(𝑡𝑎⃗⃗  ⃗, 𝑡𝑏⃗⃗  ⃗) =
𝑡𝑎⃗⃗  ⃗. 𝑡𝑏⃗⃗  ⃗
|𝑡𝑎⃗⃗  ⃗| × |𝑡𝑏⃗⃗  ⃗|
                                                                     (𝐸𝑞. 2.2) 
 
 Pearson’s correlation coefficient 
Like cosine similarity, Pearson’s correlation coefficient also illustrates the cor-
relation of two term vectors. Although the Pearson’s correlation coefficient 
formula can be represented by different forms, it has the same meaning. A 
widely used form is 
 
𝑆𝐼𝑀𝑃(𝑡𝑎⃗⃗  ⃗, 𝑡𝑏⃗⃗  ⃗) =
𝑚 ∑ 𝑤𝑡,𝑎
𝑚








         (𝐸𝑞. 2.3) 
 
where 𝑇𝐹𝑎 = ∑ 𝑤𝑡,𝑎
𝑚
𝑡=1  and 𝑇𝐹𝑏 = ∑ 𝑤𝑡,𝑏
𝑚
𝑡=1  . 
 
2.2.5 Text mining algorithms 
Text classification 
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Text classification is a popular and fundamental problem in text mining. There 
are different methods or algorithms for this problem. Here, we present only two 
algorithms, Support Vector Machines (SVMs) and Neural Networks (NNs), which are 
broadly used for text classification. 
 Support Vector Machines (SVMs) 
SVM was proposed by Vapnik et al. and widely used in data mining community 
[15]. It is one of the most effective machine learning algorithms for data classifi-
cation in general and text classification in particular. According to [16], SVMs 
outperforms substantially and significantly existing methods on classification 
tasks. Especially, since SVMs can work well with high dimensional and sparse 
data spaces, it becomes an effective algorithm for text classification. 
Additionally, SVMs can be combined with kernel methods to deal with non-
linear classification problems. The main idea of using kernel function approaches 
in SVMs is to transform original non-linear feature space into new and linear one. 
In this learning model, we can use various kernels for complex classification prob-
lems. 
 Artificial Neural Networks 
Artificial Neural Networks (ANNs), shortly called Neural Networks (NNs), are 
models which process information in a manner similar to the human brain. They 
are built up from a large number of units called as processing units or neurons, 
which are connected via links with linking weights. These neurons are unified and 
work together in order to address a certain problem in real life. Different NNs are 
designed for different applications (e.g. pattern recognition, classification, and 
clustering) through the learning process from training datasets. The main idea of 
the learning process is to modify or update the linking weights between neurons. 
There are many different NNs. Among them, Perceptron is the simplest NN 
containing only one neuron. As shown in Figure 2.5, the input nodes receive the 
real values (xi) and the output nodes produce value +1 or -1. The output of net-
work is calculated by applying activation functions to values of the input vector 
along with their weights. After that, the output value u is combined with threshold 
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Figure 2.5 Perceptron as the simplest neural network. 
 
However, more complex networks containing one or more hidden layers be-
tween input and output layers are mostly designed for real-world problems (see 
Figure 2.6). Due to NNs only work with numerical data, all real-world data such 
as images, sound, text, or time series must be transformed into numerical vectors. 
 
 
Figure 2.6 General architecture of the multi-layer neural network. 
 
Text clustering 
Also, text clustering is an important problem in text mining. It is used to find 
groups or clusters of documents (represented as vectors) having similar content. After 
clustering, all documents are partitioned into some clusters. The documents in the 
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In general, clustering results mainly depend on the distribution of the data and 
similarity measures used. However, to obtain an ideal clustering result, we should 
consider carefully different aspects of applications as well as users. There are various 
algorithms with different advantages and disadvantages. Here we introduce some 
widely-used clustering algorithms and standard evaluation methods for the text 
clustering problem. 
 Algorithms for clustering 
 Partitioning clustering algorithms 
These clustering techniques attempt to partition a dataset into K clusters by 
optimizing a given criterion. First, they select k random data points con-
sidered as k centroids of k clusters. Next, they assign data points to the 
cluster of the nearest centroids. After that, all centroids will be updated. 
This process repeats until no assignment occurs or a given condition is sat-
isfied. Simple examples of partitioning clustering algorithms are k-means, 
k-medoids [17], and PAM [18]. These algorithms are widely used in prac-
tical applications. However, one of disadvantages is that we need to first 
determine the number of clusters k. 
 
 Hierarchical clustering algorithms 
There are two opposite ways of doing hierarchical clustering [17]. In the 
first one, it starts with each data point belonging to one of the disjoint clus-
ters then the two most similar clusters are merged together, one by one. In 
contrast, the other way starts with the whole dataset considered as only one 
cluster, then split them into two most different clusters. These processes 
continue until stop conditions are satisfied. For example, figure 2.7 shows 
the result of clustering the USArrests dataset by the first algorithm above. 
The tree in the figure is called dendrogram. For treating complex and non-










Figure 2.7 An example of dendrogram. 
 
Information extraction (IE) 
Information extraction is the basic task for text mining. In some cases, IE can be 
considered as the process of feature generation for further processing of text mining. 
In other words, IE can be conducted to build the feature space for text mining. The 
process of information extraction includes two main sub-tasks as follows:  
 Named Entity Recognition (NER) 
The first step of information extraction is NER which is used to identify 
named entities mentioned in texts. Named entities include the name of per-
sons, locations, genes, diseases, drugs, chemical compounds, etc. Typically, 
NER is conducted in three steps: determining the boundaries of an entity with-
in the text, classifying this entity into a predefined class, and normalizing this 
entity to a standard name in specific domains such as biology, medicine, etc. 
To extract named entities in texts, we can use one of the following meth-
ods or combine these methods together. 
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 Dictionary-based methods 
The Dictionary-based method is the simplest approach which uses a pre-
pared dictionary of terms (represented as entities) to determine if an entity 
occurs in texts or not. In such a system, every word or group of words of 
the text is matched terms of biomedical dictionary (see Figure 2.8). If a 
term is matched in the dictionary, it is tagged. The precision of these 
methods is generally high, but its recall is poor due to the existence of 
spelling mistakes and morphological variants [20]. Furthermore, homony-





Figure 2.8 The process of the rule-based or dictionary-based approach.  
 
 Rule-based methods 
This method uses heuristic rules for recognizing entity names in texts (see 
Figure 2.8). Depending on the characteristic of different entity types, we 
can create the suitable rules for entity recognition. Each entity has differ-
ent characteristics such as the first capital letter of a word, prefixes and 
suffixes of a word, the preceding-word of a word, etc. However, it is hard 
to design the rules which are appropriate for all cases. 
 Machine-learning-based methods 
This method applies machine learning algorithms to automatically recog-
nize entities by classifying terms from texts into predefined entity 
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learning classifiers, however, it is hard to find such datasets in many ap-
plications. 
 
 Relation Extraction (RE) 
After named entities have been recognized in texts, the relations between pairs 
of these entities need to be extracted. The relation extraction is important in 
various domains because it helps us discover useful information from availa-
ble text repositories. Especially, in biomedical domain, it can be used to find 
new knowledge about genes, proteins, diseases, drugs, etc. The task of relation 
extraction is to identify relationships between pairs of recognized entities in a 
given literature resource such as Reuters-News, PubMed corpora, etc. 
Relation extraction methods are described from simple to complex ones, 
as follows: 
 Co-occurrence-based methods 
These are the simplest methods with assumption that if two entities co-
occur in sentences, paragraphs, or documents many times, they are likely 
to have some relationships together. Therefore, the main goal of these ap-
proaches is to identify if a pair of given entities appears in a piece of text 
or not. This is the simplest way to extract relations between entities. 
 
 Rule-based methods 
These methods utilize the linguistic rules (also called the patterns) as clues 
to identify particular relations. To generate these rules, we require the sup-
port from domain or linguistic experts. 
 
 Machine-learning-based methods 
These methods often rely on supervised machine learning techniques in 
order to automatically identify relations in texts. However, they typically 
require available training data which consists of given relations for learn-
ing classifiers. 
  













Chapter 3   
Materials and Methods 
 
 
In this chapter, we would like to describe about materials and approaches which used 
in the process of data preparation for biomedical information extraction. In this 
study, cancer-related PubMed abstracts and other biomedical ontologies are used as 
the input of the experimental system. Additionally, some algorithms, which are 
applied to process data, are also presented. Especially, a strategy is also proposed to 
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3.1 Overview of processing pipeline 
The processing pipeline in this study is shown in Figure 3.1. It includes four 
phases as follows:  
 Phase 1 - Text processing; 
 Phase 2 - Word embedding; 
 Phase 3 - Combination of word vectors and database information; 
 Phase 4 - Generation of drug-disease relation vectors. 
 
 
Figure 3.1 Overview of processing pipeline. Box colors indicate: light blue for corpus, light green 
for databases, yellow for word vectors, and pink for concatenated word vectors. (a), (b), (c), and 
(d) corresponding to four phases of processing pipeline. 
 
3.2 Resources and tools 
3.2.1 Biomedical databases 
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PubMed is widely used in biomedical text mining community. It allows users 
to access to a large biomedical database including the summary information of 
published biomedical articles such as author, title, abstract, keywords, etc. 
Currently, this database contains more than 24 million references to biomedi-
cal journals. 
We can access to the PubMed database via a web-based search engine 
([22, 23]). In this study, we downloaded a subset of PubMed abstracts to ex-
tract biomedical information extraction related to drugs, diseases, and genes. 
Since we are interested in drug repositioning for cancer diseases, only the can-
cer-related abstracts were downloaded.  
 Medical Subject Headings (MeSH) 
MeSH is a comprehensive controlled vocabulary thesaurus of biomedical 
terms which is created and updated by the United States National Library of 
Medical (NLM). The biomedical abstract databases like MEDLINE and Pub-
Med use the MeSH terms as a document indexing system. Most subject 
headings have a short description or definition. MeSH descriptors are arranged 
in both an alphabetic and a hierarchical tree. The tree locations contain sys-
tematic labels which are also known as tree numbers. 
In this study, we combined disease word vectors with MeSH tree num-
bers. Since we are interested in cancer or cancer-related diseases which are 
classified in “C04”, only the tree numbers beginning with “C04” are concate-
nated with disease word vectors. 
The MeSH database is yearly updated and is available online. We can 
download MeSH free of charge through the website of it [24] or we can also 
obtain it from the MeSH download page [25] in XML and other formats. 
 Pharmacogenomics Knowledgebase (PharmGKB) 
PharmGKB is a pharmacogenomics knowledge resource which is used to ag-
gregate, curate, integrate, and disseminate information about the relationships 
between human genetic variations and corresponding drug responses [26]. At 
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present, it is maintained at Stanford University. We can learn more detail 
about PharmGKB database and download from its web page [27]. 
In our research, we used PharmGKB as a dictionary for recognizing bio-
logical named entities. Additionally, it is used to transform synonyms of 
biomedical terms occurring in PubMed abstracts into their primary forms. This 
is useful for information extraction tasks such as biomedical named entity 
recognition and relation extraction. 
 DrugBank 
DrugBank is a pharmaceutical database which contains knowledge about 
drugs and drug targets. We can learn more about the DrugBank database in 
[28]. In DrugBank, Anatomical Therapeutic Chemical (ATC) code is used to 
classify active ingredients of drugs according to the system or organ. ATC 
code consists of five different levels from general level to detail level. 
Since we are interested in drug repositioning about cancer, only ATC 
codes starting from L is used to build drug word vectors in our study. To get 
DrugBank database, we can access to the home page of DrugBank [29]. 
 Comparative Toxicogenomics Database (CTD) 
CTD provides useful information regarding relationships between different 
types of biomedical objects such as chemicals, and genes, and diseases [30]. 
These relationships are manually extracted from literature by biomedical ex-
perts. Therefore, these relationships can be considered as a gold standard 
resource for biomedical applications. In scope of this study, we extracted 
drug-disease relations which are written in CTD. We can download the CTD 
database from the website [31]. 
3.2.2 Tools 
 Enju parser 
Enju is a software for parsing English sentences developed at Tsujii Laborato-
ry in Tokyo University. As a result of parsing, Enju outputs phrase structures 
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and predicate-argument structures which are useful for NLP applications such 
as information extraction, machine translation, etc.  
The Enju parser has the following advantages:  
 It is a deep parser. 
 The parsing speed and accuracy are high. 
 Specially, it can work well with large biomedical corpora. 
In our study, Enju is used for Part-Of-Speech (POS) tagging and conversion of 
words into base forms. To learn more about the Enju parser, we can refer to 
the website [32]. 
 word2vec software for word embedding 
This tool provides an effective implementation for computing vector represen-
tations of words. It was developed by Tomas Mikolov and his co-workers. It is 
an open source software and for research purposes, it can be freely download 
at [33]. 
The input of word2vec is a set of texts (saved as plain text file) and its 
output is a set of word vectors (also saved as text file). Each vector represents 
a word or a term in texts. These word vectors can be used to find similar 
words since the vectors of similar words are likely to locate close to each other 
in vector space. In addition, word analogy also is a useful function of 
word2vec. In a sense, word analogy is inference of relation. 
3.3 Data preparation 
3.3.1 Cancer-related corpus from PubMed abstracts 
As a raw corpus, we used a subset of PubMed abstracts downloaded in October 
2013, filtered by the keyword “cancer”. From 3,099,076 abstracts, 14,847,050 sen-
tences were extracted. Figure 3.2 shows an example of splitting an abstract into 
sentences. 
 




Figure 3.2 An example of splitting an abstract into sentences. 
 
3.3.2 Parsing sentences 
Enju [34] was used for POS recognition of words and conversion into base forms. 
Since the sentences were extracted from biomedical abstracts, “-genia” option was 
specified. As a result, POS and base form are recognized for each word. 
 
Figure 3.3 An example of POS tagging, base form conversion, and filtering by POS category. 
 
So that word2vec can differently treat the same word with different POS catego-
ries, they were attached right after the base form of words (e.g. “care” -> “care(V)”). 
As a key technology of rapid and low-cost drug 
development, drug repositioning is getting 
popular. In this study, a text mining approach to 
the discovery of unknown drug-disease relation 
was tested. ... 
[sentence 1] As a key technology of rapid and ... 
split into sentences 
[sentence 2] In this study, a text mining ... 
[sentence ...] ... 
As a key technology of rapid and low-cost drug 
development, drug repositioning is getting popular. 
parsing by Enju 
As a key(ADJ) technology of(P) rapid(ADJ) and 
low-cost(ADJ) drug development, drug reposition-
ing is(V) getting(V) popular(ADJ) 
keep nouns, adjectives, adverbs, and verbs 
key(ADJ) technology rapid(ADJ) low-cost(ADJ) 
drug development, drug repositioning is(V) get(V) 
popular(ADJ) 
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For readability, nouns are kept as is. To simplify the input for word2vec, we removed 
all words except nouns, adjectives, adverbs, and verbs as shown in Figure 3.3. 
3.3.3 Named entity recognition and conversion into single words 
Biological terms typically consist of two or more words. In addition, they have 
many synonyms. Since word2vec basically treats a sentence as a sequence of words, it 
is needed to recognize biological synonyms, aggregate them into primary terms, and 
convert them into single words. In this study, primary names and synonyms of drugs, 
diseases, and genes were extracted from PharmGKB [26] and used for recognition 
and aggregation (genes are used only for showing distribution of word vectors). For 
each converted single words, prefixes indicating their semantic categories were 




Figure 3.4 Single word replacement for term “yolk sac tumor” in a sentence. 
 
Related to the conversion above, we need to consider about the existence of orig-
inal single words. Firstly, if a synonym word is aggregated into primary word, the 
xxxxxxxxxxxxxx yolk sac tumor xxxxxxxxxxxxxx 
xxxxxxxxxx endodermal sinus tumor xxxxxxxxxx 
xxxxxxxxxx endodermal_sinus_tumor xxxxxxxxx 
xxxxxx disease::endodermal_sinus_tumor xxxxxx 
Synonym aggregation 
Single word replacement 
Attaching category names 
xxxxxxxxxxxxxx yolk sac tumor xxxxxxxxxxxxxx 
Named entity recognition 
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original word disappears and is not used for word embedding. Secondly, if a multi-
word term is converted into a single word, all the original single words in the multi-
word term disappear. Thirdly, if two multi-word terms occur in a sentence with 
overlapping, it is impossible to replace both of them at once. To avoid there problems, 
a sentence is converted into the sentences which containing at most one converted 
word per sentence. For example, if a sentence contains two terms to be converted, 
three sentences including original one are generated. After all conversion, 14,847,050 
sentences are expanded to 45,264,480. 
3.3.4 Word embedding 
In the field of text mining and natural language processing, computational text 
representation of a linguistic unit (e.g. documents, paragraphs, sentences, terms, and 
words) is essential. The simplest one for document is bag-of-word model in which 
each document is represented as a vector of word frequencies. In case of word repre-
sentation, only the neighboring words in the same sentence are counted. For better 
analysis, stop-words are removed and raw frequencies are modified by term weighting 
such as tf-idf. After that, these vectors are used to evaluate the characteristics of the 
units and similarities between them (vector space model).  
One of the serious problems in such a representation and analysis is high dimen-
sionality and sparseness of vectors. For instance, 10 millions of sentences may contain 
one million of different words, then the dimension of a vector is also one million. In 
addition, since frequency of word follows Zipf’s law, most of the one million of 
words only occur a few times, which makes the vectors quite sparse. Though it is 
possible to reduce the number of dimensions by PCA or LSA, this problem is not 
fully solved.  
Word embedding for distributed representation of word sense is a new approach 
to this problem. Based on neural network algorithm, reasonably short numerical 
vectors (e.g. 100 dimensions) are calculated for all words in a set of sentences. 
Through the application studies, it is proved that the vector space constructed by word 
embedding represents word senses and distances (similarities) between them quite 
well. Additionally, in this space of word sense, word analogy works well in some 
domains. For example, given three words “man”, “woman”, and “king”, word analogy 
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could predict “queen” by calculating vector(“man”) - vector(“woman”) + vec-
tor(“king”) and searching for the nearest word vector vector(“queen”). Though word 
analogy might allow wide variety of applications, the most desired one is discovery of 
unknown relations.  
In this study, we used word2vec software, a de facto standard implementation of 
word embedding algorithm, with the following parameters by default.  
 vector size = 200 
 window size = 8 
 minimum count of words to be embedded = 1 (i.e. all words) 
 model = continuous bag of words 
As a result, 1,772,186 words were embedded into word vectors (2,303 for drugs, 
3,069 for diseases, 8,703 for genes, and 1,758,111 for others). 
3.3.5 Combination of word vectors and database information 
For the evaluation of clustering results, ATC codes [35] and MeSH tree numbers 
[36] were attached to drug and disease names, respectively. ATC codes were extract-
ed from DrugBank [28]. Due to the incompleteness of data annotation, only 1,253 
drugs out of 2,303 and 2,745 diseases out of 3,069 have such classification. 
ATC code has hierarchical structure. For example, the ATC code “L01XE02” at-
tached to “drug::gefitinib” can be interpreted as follows:  
L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS 
L01: ANTINEOPLASTIC AGENTS 
L01X: OTHER ANTINEOPLASTIC AGENTS 
L01XE: Protein kinase inhibitors 
L01XE02: gefitinib 
Since we are interested in drug repositioning about cancer, ATC codes must start from 
“L”.  
  
Distributed Representation of Biomedical Words for Drug Repositioning 
31 
 
For disease name, MeSH tree number is available and it also has structured code. 
For instance, the MeSH tree number “C04.557.470.200.025.540” is attached to 
“disease:klatskin_tumour”, and its first four digits are interpreted as follows:  
C: DISEASES 
C04: Neoplasms 
C04.557: Neoplasms by Histologic Type 
C04.557.470: Neoplasms, Glandular and Epithelial 
C04.557.470.200: Carcinoma 
C04.557.470.200.025: Adenocarcinoma 
In this system, cancer or cancer-related diseases are clearly marked by the first digit 
“C04”.  
3.3.6 Generation of the special vector for drug-disease relations 
For the evaluation of difference vectors between drugs and diseases, relations be-
tween drugs and diseases occurring in the corpus were extracted from CTD [30]. The 
figure 3.5 illustrates the concatenation of drug and disease vectors to create drug-
disease relation vectors. If the relation is written in CTD with therapeutic evidence, it 
is labeled “TRUE” (otherwise, “FALSE”).  Only the 12,462 relations with therapeutic 
evidences were adopted for obtaining trustable results. In the set of relations, the 
mapping from drugs to diseases is many-to-many. For example, “drug::gefitinib” is 
related to 17 different diseases, and “disease::lung_neoplasm” is mapped from 60 
different drugs.  
 
Figure 3.5 The concatenation of drug and disease word vectors to create drug-disease relation 










In order to conduct detailed analysis on cancer-related drugs and diseases, 12,462 
extracted drug-disease relations were further filtered so that both of drug and disease 
names in each relation are attached to an ATC code and a MeSH tree number begin-
ning with “L” (Antineoplastic and immunomodulating agents) and “C04” 
(Neoplasms), respectively. As a result, 1,097 relations consist of 104 anti-cancer 
drugs and 107 cancer-related diseases were extracted for detailed analysis. 
3.4 Algorithms 
3.4.1 Checking the distribution of biomedical word vectors  
In order to check the distribution of biomedical word vectors for drugs, diseases, 
and genes, we adopted PCA to convert 200-dimension vectors into 3-dimension 
vectors and plotted in 3D space. In this study, prcomp and plot3d functions included 
in stats and rgl packages respectively for R software were used. 
3.4.2 Clustering for drugs and diseases 
For visual evaluation of word vector quality, we performed hierarchical cluster-
ing with cosine distance and Ward's method [37]. Before the clustering, 2,303 drugs 
and 3,069 diseases occurring in the corpus were reduced to 1,282 and 1,051, respec-
tively, since other drugs and diseases did not occur in CTD. In this study, we used 
hclust and plot functions included in stats and graphics packages respectively in R 
software for hierarchical clustering and visualizing clustering performance. 
3.4.3 Classification for drug-disease relations 
SVM was adopted for learning and predicting possible relations between drugs 
and diseases. As an implementation, ksvm function included in kernlab package for R 
software was used with default parameters. 
3.4.4 Cross-validation 
Cross-validation is a popular method which is used to evaluate the performance 
in classification problems. In this study, we used 10-fold cross-validation method to 
evaluate the classification performance of unseen drug-disease relations. In this 
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method, a given dataset is randomly divided into 10 equal folds. After that, the 
training and testing process is conducted 10 times by choosing alternately 1 fold for 
testing and the other 9 folds for training. To avoid the effects of random division on 
the classification performance, the 10-fold cross-validation was performed 100 times, 
and the accuracies were averaged. 
3.4.5 Methods for the class-imbalance problem 
The class-imbalance problem is also called imbalanced dataset problem. A da-
taset is considered class-imbalanced if the number of examples in some classes is 
significantly larger than in other classes. In case of two-class datasets, the minority 
class contains small amount of examples (also called positive examples), while the 
majority class consists of large amount of examples (also called negative examples). 
Such imbalanced datasets are often found in various classification problems, especial-
ly in bioinformatics. When we apply standard machine learning algorithms to 
imbalanced datasets, it often gives a poor performance. Therefore, we need to find the 
way to deal with this problem. 
To solve this problem, many strategies have been proposed. In general, they can 
be divided into two groups of methods: data level methods and algorithmic level 
methods. In this study, we applied the data level method in which corresponding to 
the number of positive examples (or correct drug-disease relations), the same number 
of negative examples (or incorrect drug-disease relations) were randomly selected, 
and used in each cross-validation as shown in Figure 3.6. 
 










subset of data for cross-validation 













Chapter 4   
Experimental Results and Discussion 
 
 
This chapter aims to illustrate the result of plotting and clustering word vectors for 
drugs and diseases. Additionally, the classification performance of drug-disease 
relation vectors is presented. We also discuss on the experimental result for explain-
ing the reason why this result is good or not good. Though further screening based on 
experts’ knowledge is necessary, this result demonstrates that the classification of 
concatenated word vector is a promising approach to in-silico screening of drug-






Distributed Representation of Biomedical Words for Drug Repositioning 
36 
 
4.1 Distribution of drug-disease-gene vectors 
Figure 4.1 illustrates the 3D plot of vectors corresponding to 2,303 drugs, 3,069 
diseases, and 8,703 genes. For visualization, the dimension of vector was reduced 
from 200 to 3 by PCA. In the top panel of the figure, it is shown that the distributions 
of word vectors in three categories are clearly separated. In the bottom panel, it is also 
shown that the frequent words have clear separation, whereas it is relatively difficult 
to discriminate the categories of rare words. 
 
 
Figure 4.1 Distribution of word vectors visualized through PCA and 3D plot. Top panel: blue, 
red, green colors indicate word vectors for drugs, diseases, and genes. Bottom panel: color 
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4.2 Cluster analysis for drug and disease vectors 
Figures 4.2 and 4.3 show the results of hierarchical clustering for drugs and dis-
eases, respectively. In the right panels of them, entire pictures of clustering results for 
1,282 drugs and 1,051 diseases are shown. In the right panel of Figure 4.2, it can be 
seen that most of the anti-cancer drugs are condensed in the ninth cluster from the top 
(left panel for more detail). It indicates that the word vectors for drugs well represent 
the characteristics of corresponding drugs. Also in Figure 4.3, we can see that the 
seventh cluster from the top contains a number of cancer-related diseases, however, 
also in sixth and ninth clusters. The difference between these results might come from 
the fact that diseases can be classified from different perspectives (tissues, mecha-
nism, etc.). 
 




Figure 4.2 Result of hierarchical clustering on drugs. Red, green, blue, yellow colors for charac-
ters indicate that the drugs are classified in ATC codes as “L01:Antineoplastic Agents”, 
“L02:Endocrine Therapy”, “L03:Immunostimulants”, and “L04:Immunosuppressants”, 
respectively.  
         





Figure 4.3 Result of hierarchical clustering on diseases. Green, yellow, red, dodgerblue, pink, 
blue, and springgreen colors for characters indicate that the diseases are classified in MeSH tree 
numbers as “C04.182:Cysts”, “C04.445:Hamartoma”, “C04.557:Neoplasms by Histologic Type”, 
“C04.588:Neoplasms by Site”, “C04.697:Neoplastic Processes”, “C04.730:Paraneoplastic 
Syndromes”, and “C04.834:Precancerous Conditions”.   
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4.3 Classification of drug-disease relations 
4.3.1 Applicability of simple word analogy to drug-disease relations 
Though word analogy is quite attractive, it does not always works well. To evalu-
ate the applicability of word analogy to the discovery of new relation between drug 
and disease, checked whether most of the displacement vectors between confirmed 
drug-disease pairs (i.e. correct relations) are similar in length and parallel to each 
other or not. Unfortunately, as shown in Figure 4.4, the displacement vectors have 
wide range of lengths and directions. It indicates that the simple application of word 
analogy to drug repositioning cannot achieve high performance.  
 
 
Figure 4.4 Distribution of displacement vectors for cancer-related drug-disease relations in CTD. 
Blue and red points represents anti-cancer drugs and cancer-related diseases.  
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4.3.2 Classification of unseen drug-disease relations 
Instead of simple application of word analogy, we constructed a classification 
model using SVM. For all combinations of 104 anti-cancer drugs and 107 cancer-
related diseases (i.e. 11,128 drug-disease pairs), drug vectors and disease vectors were 
concatenated and binary class labels (i.e. positive or negative) were added according 
to 1,097 correct drug-disease relations extracted from CTD. Due to the imbalance of 
two classes, 1,097 out of 10,031 negative examples were randomly selected so that 
the numbers of positive and negative examples are balanced (see Figure 3.6).  
The result of performance evaluation is shown in Table 4.1. Each accuracy is an 
average of 100 times 10-fold cross-validation with different subsets of negative 
examples. In this table, it was revealed that the performance of classification was not 
so affected by vector size and window size, and the best accuracy was 87.6%. For 
exploratory use of the classification model to discover candidate drug-disease pairs, it 
means sufficiently high performance.  
Table 4.1 Accuracy of classifying correct and incorrect drug-disease relations by SVM 
vector size 
accuracy 
window size = 2 window size = 3 window size = 4 window size = 8 
50 0.872 0.873 0.875 0.872 
75 0.873 0.874 0.874 0.874 
100 0.874 0.874 0.874 0.876 
200 0.874 0.874 0.874 0.874 
 
Finally, we tested all combinations of 2,199 drugs not used in training and 107 
cancer-related diseases (in total, 235,293 drug-disease pairs). In case of the classifica-
tion model trained by 11,128 examples, only 64 test examples were predicted as 
positive, and all the drugs in the examples were anti-cancer drugs (but not included in 
104 anti-cancer drugs used for training). By controlling the degree of class imbalance 
in training data, it is possible to predict a pair of non-anti-cancer drug and cancer-
related disease as positive. For example, using the classification model trained by 
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1,097 positive and 8,776 negative examples (degree of imbalance is 1:8), 10 times 
training and test by 235,293 drug-disease pairs discovered the following candidate 
drugs for repositioning to cancer treatment, where the numbers indicate how many 
times they were discovered in 10 times training and test.  
drug::urokinase(10), drug::photodynamic_therapy(10),  drug::oxygen(10),  drug::nonoxynol-9(10),   
drug::nitroglycerin(10),  drug::nitrogen(10),  drug::l-phenylalanine(10),  drug::l-methionine(10),   
drug::l-glutamine(10),  drug::l-cysteine(10),  drug::glutathione(10),  drug::glucose(10),   
drug::epoxide(10),  drug::enzyme(10),  drug::collagenase(10),  drug::bisphosphonate(10),   
drug::amino_acid(10),  drug::amide(10),  drug::clarithromycin(9),  drug::vitamin(8),  drug::l-proline(7),   
drug::vitamin_e(6),  drug::xanthophyll(4),  drug::phospholipid(4),  drug::palifermin(4),  drug::ether(4),   
drug::ethacrynic_acid(4),  drug::denosumab(4),  drug::egfr_inhibitor(2),  drug::pyruvic_acid(1).  
Besides too general names like “drug::enzyme” and “drug::amide”, it is notable 
that the above list includes approved anti-cancer drugs (e.g. “drug::denosumab”), anti-
cancer drugs under investigation (e.g. “drug::clarithromycin”, 
“drug::bisphosphonate”, and “drug::xanthophyll”), and drugs potentially promote 
cancer (e.g. “drug::urokinase” and “drug::collagenase”). Especially, it should be 
emphasized that repositioning of clarithromycin to anti-cancer agent has been report-
ed in 2015 [38], despite the fact that the corpus was downloaded in 2013. Though 
further screening based on expert’s knowledge is necessary, this result demonstrate 
that the classification of concatenated word vector is a promising approach to in-silico 

















Chapter 5   
Conclusion and Future Works 
 
 
In this chapter, we would like to summarize main works that we have done in our 
research. In order to go on this study in the future, we introduce some strategies for 
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5.1 Dissertation summary 
It can be said that the development of new and effective drugs always plays an 
important role for pharmaceutical companies and institutes. As a key technology of 
rapid and low-cost drug development, drug repositioning is getting more popular. In 
general, drug repositioning is reuse of existing drugs for other purposes. 
Besides biological trial and error, computational approaches are actively tested 
for drug repositioning. In this study, we applied text mining techniques to drug 
repositioning in order to (i) check the distribution of biomedical words; (ii) analyze 
clustering of anti-cancer drug vectors and cancer-related disease vectors; (iii) find 
unseen drug-disease relations by classification. 
One of the reasons why word embedding by word2vec becomes popular is its 
functionality of word analogy [6]. For example, if a sufficient amount of corpus is 
converted into word vectors and used in the analogy, it could predict fourth word 
“California” from three given words “Chicago”, “Illinois”, and “Stockton”. Since a 
state for a city is unique, it works well: it readily means that the analogy easily fails 
for one-to-many relationship (e.g. predicting “Stockton” from “Illinois”, “Chicago”, 
and “California”). About drug-disease relationship, at first we expected that one drug 
is used for basically one disease. However, as shown in Figure 4.4, it was one-to-
many from both sides of drug-disease relation. For another problem like gene-protein 
relationship, accuracy of word analogy might be high since only one protein is 
produced from one gene, ignoring alternative splicing. 
Although word analogy was not available, word2vec provided significant ad-
vantages in the text mining from large amount of biomedical texts in this study. It 
efficiently encoded more than 1.7 million words into quite short vectors (e.g. 200 
dimensions). If we use traditional word frequency and vector space model, one vector 
for a word is a vector of 1.7 million features with extremely high sparsity. Due to the 
efficiency of encoding, we could process the whole corpus in reasonable memory 
space and computation time. Furthermore, the word vectors generated by word2vec 
seem well reflect the semantic space of biomedical words. Figure 4.1 illustrates that 
the words in different semantic categories are well separated in case of sufficiently 
high frequency of occurrences. Also, the results of clustering shown in Figures 4.2 
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and 4.3 indicate that similarities among words in the same category are also fine. 
They might be promising results for further application of word embedding in bio-
medical text mining. 
In this study, it was revealed that word embedding is effective for representing 
sense of all words in large amount of cancer-related PubMed abstracts. Furthermore, 
concatenation of word vectors of drugs and diseases well represents their relations and 
could be used for finding candidate drugs for repositioning by classification. 
5.2 Future works 
In this study, we mainly focused on the prediction of drug-disease relations in or-
der to find new indications of existing drugs for the treatment of cancer diseases. We 
hope that this model will also be applied to other kind of diseases in the future. 
Moreover, new kinds of biomedical relations such as gene-disease relations or drug-
gene relations will be discovered by a similar model. 
For better performance of classification, various feature selection and over-
sampling algorithms [39] will be tested in the future work. 
To check the effects of quantity and quality of the training data on the quality of 
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